Palmar plantar erythrodysesthesia historical perspective: Difference between revisions

	Palmar plantar erythrodysesthesia Microchapters
Home
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Palmar plantar erythrodysesthesia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Palmar plantar erythrodysesthesia historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Palmar plantar erythrodysesthesia historical perspective
CDC on Palmar plantar erythrodysesthesia historical perspective
Palmar plantar erythrodysesthesia historical perspective in the news
Blogs on Palmar plantar erythrodysesthesia historical perspective
Directions to Hospitals Treating Palmar plantar erythrodysesthesia
Risk calculators and risk factors for Palmar plantar erythrodysesthesia historical perspective

Revision as of 18:19, 26 June 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief:

In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma ¹.

The following are a few famous cases of [disease name]:

@@ Line 5: / Line 5: @@
 ==Historical Perspective==
-===Discovery===
+ In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma <sup>1</sup>.
-* There is limited information about the historical perspective of [disease name].
-OR
-*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
-*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
-*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
-*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
 ===Landmark Events in the Development of Treatment Strategies===